Sign In
|
Register
|
About Corte Madera
|
Contact Us
Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast
|
Traffic
Corte Madera News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Corte Madera Gas Prices
Ski And Snow Reports
Financial Markets
American
American
Bakery
Asian
Brew Pubs
Bakery/Breakfast
California Cuisine
Coffee Houses
Chinese
Eating Places
Fast Food
Coffee Houses
Delicatessens
German
Fast Food
Greek
Hawaiian
Dessert, Ice Cream and Frozen Yogurt
Italian
Dog Friendly
Italian/Pizza
Jewish
Latin American
Lebanese
Mediterranean
Pizza
Seafood
Soul Food
Sports Bars
Steaks, Chops
Thai
Wine
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Attractions
Nightlife
Family Activities
Arts & Culture
Annual Events
Accommodations
Hotel and Motel Management
Hotels & Resorts
Apartments
Apartment Finding & Rentals
Apartments
Senior Apartments
Art & Culture
Galleries & Dealers
Associations, Foundations and Organizations
Business & Professional Clubs
Chambers of Commerce
Civic, Social and Fraternal
Labor Unions and Labor Organizations
Non-Profits
Professional & Trade Associations
Sales Organizations
Attractions & Entertainment
Air Tours
Amusement & Water Parks
Galleries
General Attractions
Jeep & Hummer Tours
Parks & Preserves
Theatre
Tours
ATV & Hummer Tours
Automotive
Auto Rental
Dealers - Antique & Classic
Dealers - New
Dealers - Used
Motorcycles
Parts & Supplies
Repair & Service
Beauty & Fitness
Barbers
Beauty Salons
Dance Clubs & Studios
Fitness Programs
Health Clubs & Gyms
Weight Loss
Business & Professional Services
Appraisers
Building Maintenance & Janitorial
Business & Labor Organizations
Business Legal Services
Computer & Audio Visual Services
Consultants
Copier & Fax Services, Equipment
Data Processing Service
Durable Goods
Employment Services, Placement & Agencies
Energy Services
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Graphic Design & Art
Human Resource Services
Management Services
Marketing & Advertising Services
Media Services
Office Furniture, Equipment & Supplies
Office Supplies
Printing & Publishing
Public Relations & Publicity
Research
Security & Investigative Services
Signs & Banners
Staffing & Support Services
Telecommunications
Trucking & Hauling
Video Production
Waste Management & Recycling
Wholesale
Commercial Contractors
Contractors
Architects
Building Contractors & Consultants
Carpentry
Concrete
Drywall, Plastering & Insulation
Electric
Floors & Ceilings
General Contractors
Heating, Cooling & AC
Landscaping
Painting & Wallcovering
Plumbing
Roofing
Special Trade Contractors
Domestic Services
Child Care Services
Pet Sitting and Day Care
Education
Art Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Middle Schools
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment
Employment Agencies
Find or Post a Job
Temporary Help & Employment Contractors
Financial Services
Accountants & Tax
Appraisers
Banks & Credit Unions
Bookkeeping
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Investments
Loans
Misc. Financial Services
Mortgage Lenders
Personal
Golf
Government
City & County Government
Federal Government
National Government
State Government
Health and Medicine
Alternative Medicine / Acupuncture
Animal Health
Chiropractors
Counseling
Dentistry
Drug Stores & Pharmacies
Emergency Services
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Massage
Medical Doctors
Mental Health
Nutrition
Physicians & Surgeons
Public Health & Safety
Social Services
Specialists - Health Care Professionals
Home & Garden
Accessories
Carpets & Rugs
Cleaning Supplies & Services
Contractors
Floor Coverings
Furniture
Heating, Cooling & AC
Home Improvement Centers
Lamps & Lighting
Lawn & Garden
Masonry & Stone Work
Nurseries & Garden Centers
Painting & Wallcoverings
Plumbing
Roofing & Siding
Water Supply
Insurance
Agents & Brokers
Auto
Health
Home
Life
Pets
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Audio & Visual
Computers, Electronics & Telecommunications
Industrial Supplies & Services
Media
Print Publications
Radio Stations
Television Stations
Meeting & Event Planning
Travel Arrangement & Services
Miscellaneous
Nightlife
Bars and Lounges
Dinner & Music Theatres
Live Music
Night Clubs
Personal Service
Barbers, Beauty Salons & Spas
Shoe Repair
Pets
Pet Shops
Pet Supplies & Food - Retail
Training
Veterinary Hospitals
Real Estate
Appraisers
Commercial
Condominiums
Developers
Mortgage Lenders
Property Management
Real Estate Agents and Brokers
Residential
Religion
Relocation
Movers
Storage
Restaurants
Bakery
Brew Pubs
Eating Places
Fast Food
Sports Bars
Steaks, Chops
Wine
Shopping
Accessories
Books
Cellular & Wireless
Children's and Infants Clothing
Clothing
Computer and Computer Software
Convenience Stores
Department Stores
Discount Stores
Electronics
Flowers
Furniture
Gifts & Specialty Shops
Gourmet & Specialty Foods
Grocery Stores
Health Food Stores
Hobbies & Crafts
Home Improvement
Indian Arts & Crafts - Retail
Jewelry
Men's Clothing Stores
Notions
Office Supplies & Service
Pharmacies
Resale Shops
Shoe Stores
Sporting Goods
Thrift Stores
Toy Stores
Videos
Women's Clothing Stores
Spas
Beauty Salons
Sports & Recreation
Arenas and Venues
Associations & Clubs
Bicycles
Dance Clubs & Studios, Instruction
Fishing, Fishing Charters and Tours
Golf Courses
Golf Equipment & Supplies
Health Clubs
Instruction
Martial Arts
Recreation Facilities
Sporting Goods
Technology
Communications
Computer Maintenance and Repair
Computer Services & Consultants
E-commerce
Internet Advertising & Services
Semiconductor
Software
Web Design
Web Development
Travel & Transportation
Auto Rentals
Hotels & Resorts
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Entertainment
Florists
Health & Beauty
Photographers & Videographers
Transportation
Apartments
Classifieds
Cars
Forums
Coupons
News Archives
Contests
Jobs
Search Hotels in Corte Madera
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inhibikase Therapeutics Inc
(NQ:
IKT
)
2.800
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Inhibikase Therapeutics Inc
< Previous
1
2
Next >
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
November 14, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Closing of up to $275 Million Financing and Advancement of IkT-001Pro into a Late Stage Clinical Trial in Pulmonary Arterial Hypertension
October 21, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro, an Optimized Prodrug of Imatinib, into a Late-Stage Trial in Pulmonary Arterial Hypertension
October 09, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
August 14, 2024
Company to host conference call on August 15, 2024 at 8:00 a.m. ET
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
August 07, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s Disease
June 17, 2024
Company expects to report trial results in 4Q24
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
June 05, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 Million
May 20, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity
May 15, 2024
Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ET
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement
May 15, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension
May 09, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
April 18, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension
April 03, 2024
Meeting to discuss potential of IkT-001Pro as a disease modifying treatment for Pulmonary Arterial Hypertension
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
March 27, 2024
Company to host conference call on Thursday, March 28, 2024 at 8:00 a.m. ET
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics to Provide Trial Update for Risvodetinib at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
March 07, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro
February 28, 2024
Company to pursue eleven indications for IkT-001Pro; all previously approved for treatment with imatinib mesylate
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers
February 07, 2024
- The Company continues to progress the 201 Trial evaluating risvodetinib in untreated Parkinson’s disease -
From
Inhibikase Therapeutics
Via
GlobeNewswire
Dr. Milton Werner, CEO of Inhibikase Therapeutics, Inc. is Featured in an Interview With SmallCapsDaily
February 05, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
January 29, 2024
Via
AB Newswire
Topics
Retirement
Exposures
Pension
Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib
January 29, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli
January 16, 2024
Joseph Frattaroli to retire at end of 1Q24; Garth Lees-Rolfe, Vice-President of Finance, to be promoted to Chief Financial Officer
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
December 19, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Granted Pre-NDA Meeting with the FDA for IkT-001Pro
December 04, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity
November 14, 2023
Company to host conference call on Wednesday, November 15, 2023 at 8:00 a.m. ET
From
Inhibikase Therapeutics
Via
GlobeNewswire
Correcting & Replacing -- Inhibikase Therapeutics to Report Third Quarter Financial Results on November 14, 2023
November 07, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics to Report Second Quarter Financial Results on November 14, 2023
November 07, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Highlights Unblinded Functional Analysis from the 201 Trial of Risvodetinib in Untreated Parkinson’s Disease and Provides Update on Ongoing Enrollment
October 16, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy
October 04, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Shares Of Inhibikase Therapeutics Stock Decouples From NASDAQ Weakness; Jump 8% Including A/H Wednesday As Interest In Ikt-148009 Intensifies ($IKT)
March 16, 2023
Via
AB Newswire
Exposures
Product Safety
Inhibikase Therapeutics Stock Turns Bullish After FDA Lifts Full Clinical Hold For Lead Candidate IkT-148009 ($IKT)
March 14, 2023
Via
AB Newswire
Exposures
Product Safety
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Calendar
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.